Genomic promise: Personalized medicine for ophthalmology

Archives of Ophthalmology

Volumn 126, Issue 3, 2008, Pages 422-423

  Wiggs, Janey L ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEVACIZUMAB; CORTICOSTEROID DERIVATIVE; RANIBIZUMAB; SULFONAMIDE; TOPIRAMATE; VASCULOTROPIN RECEPTOR;

CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; DISEASE COURSE; DISEASE PREDISPOSITION; EDITORIAL; GENE MUTATION; GENE REPLACEMENT THERAPY; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC DISORDER; GENOTYPE; GLAUCOMA; HEALTH CARE; HUMAN; INTRAOCULAR PRESSURE; LEBER CONGENITAL AMAUROSIS; MEDICAL DECISION MAKING; NONHUMAN; PHARMACOGENOMICS; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; SIDE EFFECT;

DELIVERY OF HEALTH CARE; EYE DISEASES; GENOMICS; HUMANS; OPHTHALMOLOGY; PERSONAL HEALTH SERVICES;

EID: 40849145464     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.3.422     Document Type: Editorial

References (18)

1. Despriet DD, Klaver CC, van Duijn CC, Janssens AC. Predictive value of multiple genetic testing for age-related macular degeneration. Arch Ophthalmol. 2007; 125(9):1270-1271.
2. Klein R. Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol. 2007;14(4):184-187.
3. Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007; 317(5843):1397-1400.
4. Hewitt AW, Sharma S, Burdon KP, et al. Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum Mol Genet. 2007.
5. Fingert JH, Alward WL, Kwon YH, et al. LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States. Am J Ophthalmol. 2007;144(6):974-975.
6. Hewitt AW, Mackey DA, Craig JE. Myocilin allele-specific glaucoma phenotype database. Hum Mutat. 2007.
7. Stone EM. Leber congenital amaurosis: a model for efficient genetic testing of heterogeneous disorders, LXIV Edward Jackson Memorial Lecture. Am J Ophthalmol. 2007;144(6):791-811.
8. Acland GM, Aguirre GD, Bennett J, et al. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther. 2005;12(6):1072-1082.
9. Jacobson SG, Acland GM, Aguirre GD, et al. Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection. Mol Ther. 2006;13(6):1074-1084.
10. Schwartz SG, Puckett BJ, Allen RC, Castillo IG, Leffler CT. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers. Ophthalmology. 2005;112(12):2131- 2136.
11. Reiche EM, Bonametti AM, Voltarelli JC, Morimoto HK, Watanabe MA. Genetic polymorphisms in the chemokine and chemokine receptors: impact on clinical course and therapy of the human immunodeficiency virus type 1 infection (HIV-1). Curr Med Chem. 2007;14(12):1325-1334.
12. Tiwari V, Shukla SY, Yue BY, Shukla D. Herpes simplex virus type 2 entry into cultured human corneal fibroblasts is mediated by herpesvirus entry mediator. J Gen Virol. 2007;88(Pt 8):2106-2110.
13. Kariyazono H, Ohno T, Khajoee V, et al. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res. 2004;56(6):953-959.
14. Mitchell P, Cumming RG, Mackey DA. Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology. 1999;106(12):2301-2306.
15. Rozsa FW, Reed DM, Scott KM, Pawar H, Moroi SE, Kijek TG, Krafchak CM, Othman MI, Vollrath D, Elner VM, Richards JE. Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure. Mol Vis. 2006;12:125-141.
16. Santaella RM, Fraunfelder FW. Ocular adverse effects associated with systemic medications: recognition and management. Drugs. 2007;67(1):75-93.
17. Sankar PS, Pasquale LR, Grosskreutz CL. Uveal effusion and secondary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol. 2001; 119(8):1210-1211.
18. Stone EM. Genetic testing for inherited eye disease. Arch Ophthalmol. 2007;125 (2):205-212.